RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

被引:54
|
作者
Hoette, Susana [1 ]
Creuze, Nicolas [2 ]
Gunther, Sven [3 ]
Montani, David [3 ]
Savale, Laurent [3 ]
Jais, Xavier [3 ]
Parent, Florence [3 ]
Sitbon, Olivier [3 ]
Rochitte, Carlos Eduardo [4 ]
Simonneau, Gerald [3 ]
Humbert, Marc [3 ]
Souza, Rogerio [1 ]
Chemla, Denis [2 ]
机构
[1] Univ Sao Paulo, Inst Heart, Dept Pulm, Sch Med, Ave Dr Eneas de Carvalho Aguiar,44, BR-05403000 Sao Paulo, Brazil
[2] APHP, Physiol & Radiol, Fac Med Paris 11, EA4533, Le Kremlin Bicetre, France
[3] Paris11 Univ, APHP, Pneumol, Inserm,UMR S999, Le Kremlin Bicetre, France
[4] Univ Sao Paulo, Inst Heart, Cardiovasc Imaging, Sch Med, Sao Paulo, Brazil
关键词
Right ventricular dysfunction; Pulmonary hypertension; Cardiac ventricles; Hemodynamics; RVFAC; TAPSE; CARDIAC MAGNETIC-RESONANCE; TRICUSPID ANNULAR MOTION; ARTERIAL-HYPERTENSION; THERAPY; HEMODYNAMICS; PRESSURE; SURVIVAL; MRI;
D O I
10.1007/s00408-018-0089-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The right ventricular ejection fraction (RVEF) is a surrogate marker of right ventricular function in pulmonary hypertension (PH), but its measurement is complicated and time consuming. The tricuspid annular plane systolic excursion (TAPSE) measures only the longitudinal component of RV contraction while the right ventricular fractional area change (RVFAC) takes into account both the longitudinal and the transversal components. The aim of our study was to evaluate the relationship between RVEF, RVFAC, and TAPSE according to hemodynamic severity in two groups of patients with PH: pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Fifty-four patients with PAH (n = 15) and CTEPH (n = 39) underwent right heart catheterization and cardiac magnetic resonance (CMR). The ventricular volumes and areas, TAPSE, and eccentricity index were measured. The RVFAC was more strongly correlated with the RVEF (r = 0.81, p < 0.0001) than the TAPSE (r = 0.63, p < 0.0001). RVEF < 35% was better predicted by the RVFAC than the TAPSE (TAPSE: AUC = 0.77 and RVFAC: AUC = 0.91; p = 0.042). In the group with the worse hemodynamic status, the RVFAC correlated much better with the RVEF than the TAPSE. There were no significant differences in the CMR data analyzed between the groups of PAH and CETPH patients. The RVFAC is a good index to estimate RVEF in PH patients; even better than the TAPSE in patients with more severe hemodynamic profile, possibly for including the transversal component of right ventricular function in its measurement. Furthermore, RVFAC performance was similar in the two PH groups (PAH and CTEPH).
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [1] RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study
    Susana Hoette
    Nicolas Creuzé
    Sven Günther
    David Montani
    Laurent Savale
    Xavier Jaïs
    Florence Parent
    Olivier Sitbon
    Carlos Eduardo Rochitte
    Gerald Simonneau
    Marc Humbert
    Rogerio Souza
    Denis Chemla
    Lung, 2018, 196 : 157 - 164
  • [2] Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis
    Trushenko, Natalia V. V.
    Suvorova, Olga A. A.
    Nekludova, Galina V. V.
    Levina, Iuliia A. A.
    Chikina, Svetlana Y. Y.
    Nikolenko, Alexandra M. M.
    Tsareva, Natalia A. A.
    Volkov, Alexandr V. V.
    Yaroshetskiy, Andrey I. I.
    Merzhoeva, Zamira M. M.
    Nuralieva, Galiya S. S.
    Avdeev, Sergey N. N.
    LIFE-BASEL, 2023, 13 (06):
  • [3] Clinical study of right ventricular longitudinal strain for assessing right ventricular dysfunction and hemodynamics in pulmonary hypertension
    Li, Yidan
    Wang, Yidan
    Ye, Xiaoguang
    Kong, Lingyun
    Zhu, Weiwei
    Lu, Xiuzhang
    MEDICINE, 2016, 95 (50) : e5668
  • [4] High altitude pulmonary hypertension with severe right ventricular dysfunction
    Maripov, Abdirashit
    Mamazhakypov, Argen
    Karagulova, Gulnura
    Sydykov, Akylbek
    Sarybaev, Akpay
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : E89 - E90
  • [5] Right ventricular dysfunction in pulmonary hypertension
    Song, Ze-Zhou
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (02) : 232 - 232
  • [6] Significance of Electrocardiographic Right Ventricular Hypertrophy in Patients with Pulmonary Hypertension with or without Right Ventricular Systolic Dysfunction
    Nagai, Toshiyuki
    Kohsaka, Shun
    Murata, Mitsushige
    Okuda, Shigeo
    Anzai, Toshihisa
    Fukuda, Keiichi
    Satoh, Toru
    INTERNAL MEDICINE, 2012, 51 (17) : 2277 - 2283
  • [7] Pulmonary hypertension and right ventricular dysfunction in hemodialysis patients
    Zhao, L. -J.
    Huang, S. -M.
    Liang, T.
    Tang, H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (21) : 3267 - 3273
  • [8] Global and Regional Right Ventricular Dysfunction in Pulmonary Hypertension
    Calcutteea, Avin
    Lindqvist, Per
    Soderberg, Stefan
    Henein, Michael Y.
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2014, 31 (02): : 164 - 171
  • [9] Parenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction
    Hinkamp, Colin A.
    Shah, Trushil
    Bartolome, Sonja
    Torres, Fernando
    Chin, Kelly M.
    JOURNAL OF THORACIC DISEASE, 2021, 13 (03) : 1466 - 1475
  • [10] Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy
    van de Veerdonk, Marielle C.
    Kind, Taco
    Marcus, J. Tim
    Mauritz, Gert-Jan
    Heymans, Martijn W.
    Bogaard, Harm-Jan
    Boonstra, Anco
    Marques, Koen M. J.
    Westerhof, Nico
    Vonk-Noordegraaf, Anton
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (24) : 2511 - 2519